TOPLINE: Neoadjuvant semaglutide administered before metabolic and bariatric surgery (MBS) did not improve overall weight loss or safety outcomes in patients with obesity and metabolic diseases. […]

TOPLINE: The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in patients with metabolic dysfunction–associated steatotic liver disease (MASLD) was associated with a reduced risk […]

TOPLINE: An elimination diet guided by a novel irritable bowel syndrome (IBS)–specific immunoglobulin G (IgG) assay reduced abdominal pain in a greater proportion of patients with […]

TOPLINE: Patients with advanced hepatocellular carcinoma (HCC) receiving atezolizumab-bevacizumab treatment were more likely to experience variceal bleeding if they had a low platelet count, main portal […]

TOPLINE: Scores on a broad panel of blood metabolomic markers may predict inflammatory bowel disease (IBD) up to 10 years before onset, indicated a new study […]

TOPLINE: Fecal calprotectin (FC) levels were significantly associated with disease activity and extent in ulcerative colitis and also predicted mucosal healing. METHODOLOGY: Researchers conducted a single-center […]

TOPLINE: Patients with steatotic liver disease (SLD) showed an elevated risk for colorectal cancer (CRC), with the highest risk observed in those with alcohol-associated liver disease […]